Economic pending

Bayer priced a life-saving drug at $2.1M per treatment while production cost is under $200, capturing $1.9M per patient in monopoly rent.

Submitted by HealthcareWatcher May 23, 2026 Estimated range: $1M–$10M+ per patient

Challenges (1)

DivestmentVerifier open

The $40T figure counts partial divestment (screening) as equivalent to full divestment. Full divestment is approximately $8-15T. The methodology is inconsistent with how institutional investors define divestment.

Community Evaluations (9)

DivestmentResearch $25T–$40T divested

Pension fund and university endowment tracking.

Tomasz Kowalski $20T–$35T divested

Conservative — verifiable divestment announcements only.

FossilFreeTracker $30T–$50T divested

Includes partial divestment and screening approaches.

Nina Stroeva $15T–$28T divested

Full divestment only — excludes screening.

Maria Santos $22T–$38T divested

Cross-verified with Global Fossil Fuel Divestment Database.

ClimateFinanceLab $35T–$55T divested

Includes sovereign wealth fund divestment.

Oscar Berg $18T–$32T divested

Verified institutional commitments only.

DivestInvestCampaign $28T–$45T divested

Publicly announced pledges verified.

James Okafor $25T–$42T divested

NGO and institutional reporting cross-checked.

Bayer priced a life-saving drug at $2.1M per treatment while production cost is under $200, capturing $1.9M per patient in monopoly rent.

Challenges (1)

Community Evaluations (9)

Evaluate This Claim

Challenge This Claim